Arancibia-Cárcamo, I. Lorena;
Yuen, Eunice Y.;
Muir, James;
Lumb, Michael J.;
Michels, Guido;
Saliba, Richard S.;
Smart, Trevor G.;
Yan, Zhen;
Kittler, Josef T.;
Moss, Stephen J.
Ubiquitin-dependent lysosomal targeting of GABA A receptors regulates neuronal inhibition
Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
Medientyp:
E-Artikel
Titel:
Ubiquitin-dependent lysosomal targeting of GABA A receptors regulates neuronal inhibition
Beteiligte:
Arancibia-Cárcamo, I. Lorena;
Yuen, Eunice Y.;
Muir, James;
Lumb, Michael J.;
Michels, Guido;
Saliba, Richard S.;
Smart, Trevor G.;
Yan, Zhen;
Kittler, Josef T.;
Moss, Stephen J.
Erschienen:
Proceedings of the National Academy of Sciences, 2009
Erschienen in:
Proceedings of the National Academy of Sciences, 106 (2009) 41, Seite 17552-17557
Sprache:
Englisch
DOI:
10.1073/pnas.0905502106
ISSN:
0027-8424;
1091-6490
Entstehung:
Anmerkungen:
Beschreibung:
The strength of synaptic inhibition depends partly on the number of GABA A receptors (GABA A Rs) found at synaptic sites. The trafficking of GABA A Rs within the endocytic pathway is a key determinant of surface GABA A R number and is altered in neuropathologies, such as cerebral ischemia. However, the molecular mechanisms and signaling pathways that regulate this trafficking are poorly understood. Here, we report the subunit specific lysosomal targeting of synaptic GABA A Rs. We demonstrate that the targeting of synaptic GABA A Rs into the degradation pathway is facilitated by ubiquitination of a motif within the intracellular domain of the γ2 subunit. Blockade of lysosomal activity or disruption of the trafficking of ubiquitinated cargo to lysosomes specifically increases the efficacy of synaptic inhibition without altering excitatory currents. Moreover, mutation of the ubiquitination site within the γ2 subunit retards the lysosomal targeting of GABA A Rs and is sufficient to block the loss of synaptic GABA A Rs after anoxic insult. Together, our results establish a previously unknown mechanism for influencing inhibitory transmission under normal and pathological conditions.